Contemporary trends in the utilization of second-line pharmacological therapies for type 2 diabetes in the United States and the United Kingdom.

Devin Abrahami,Elvira D'Andrea,Hui Yin,Seoyoung C Kim,Julie M Paik,Deborah Wexler,Laurent Azoulay,Elisabetta Patorno

Diabetes, obesity & metabolism（2023）

引用 1|浏览11

暂无评分

摘要

This international cohort study shows that sulphonylureas remain the most common second-line medications prescribed following metformin in both the United States and the United Kingdom. Despite recommendations, the use of newer glucose-lowering therapies with cardiovascular benefits remains low.

查看译文

关键词

cardiovascular disease, cohort study, drug utilization, glucose-lowering medications, pharmacoepidemiology, type 2 diabetes

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要